BK Virus clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

    Sorry, accepting new patients by invitation only

    To evaluate the association between time-updated CMV and BK viral loads measured monthly by T-ID and the risk of CMV disease and/or biopsy-proven BK virus-associated nephropathy (BKVAN) during the first 12 months following kidney transplantation, accounting for the net immune environment (TTV viral load) and allograft injury (donor-derived cell-free DNA, dd-cfDNA).

    at UCLA

Last updated: